Customer bookings nearly doubled compared to Q2, with a stronger backlog entering Q4 2025 Recent Hire of U.S. Federal Sales leadership Supports market Opportunities Reorganization and efficiency plan on track toward annualized 15–20% operating expense reduction Cybersecurity, HW and software sales expand across telecom and infrastructure networks FREMONT, Calif, Nov. 14, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today reported financial results for the third quarter and nine months ended September 30, 2025. “We are seeing good traction and opportunities develop in Federal and MDU markets, despite a soft quarter on the Federal revenue side,” said Tuvia Barlev, Chairman and...

Topline data from Phase 3 (IOB-013) clinical trial in advanced melanoma presented at ESMO; data highlights improvements in PFS achieved in overall population and across virtually all subgroups, although statistical significance on the PFS primary endpoint was narrowly missed Meeting scheduled with FDA in December to align on the design of a potential new Phase 3 registrational trial for IO102-IO103 in patients with advanced melanoma Pre-clinical data for additional T-win platform pipeline candidates IO112 targeting arginase 1 and IO170 targeting transforming growth factor (TGF)-β were presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting Ended the third quarter with approximately $31 million in cash and cash equivalents, which is expected to support operations through the first quarter of 2026 Corporate presentations...

NEW PORT RICHEY, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) — Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a Florida-based provider of residential solar and commercial long-duration energy-storage solutions, today reported financial results for the third quarter and nine months ended September 30, 2025. Recent Financial and Operational HighlightsThird quarter net revenue was approximately $23.9 million, a 32% increase from the second quarter and a 22% increase from the third quarter of 2024. Third quarter Adjusted EBITDA, a non-GAAP financial measure, was $2.0 million, an improvement from $1.4 million in the second quarter and $(0.2) million in the third quarter of 2024. The Company’s completed acquisition, during the third quarter, of Heliogen, a provider of on-demand clean energy technology solutions, provides...

Third Quarter 2025 vs. Third Quarter 2024Revenue of $19.3 million compared to $19.4 million; Gross profit of $4.3 million compared to $4.2 million; Gross margin of 22.3% compared to 21.7%; Net income of $1.1 million compared to net income of $0.7 million; Earnings per share of $0.09 compared to earnings per share of $0.06; EBITDA(1) of $1.9 million compared to $1.7 million.Nine Months 2025 vs. Nine Months 2024Revenue of $49.8 million compared to $59.3 million; Gross profit of $6.6 million compared to $12.9 million; Gross margin of 13.3% (20.4% excluding A-10 Program impact) compared to 21.7%; Net (loss) income of $(1.5) million compared to net income of $2.3 million; (Loss) earnings per share of $(0.12) compared to earnings per share of $0.19; Adjusted EBITDA(1) of $(0.6) million ($3.9 million excluding A-10 Program impact) compared...

Company continues growth momentum, reduces net loss 90.3% over prior year quarter, and accelerates path to Adjusted EBITDA breakevenImproving Fiscal Q2 and Record Six-Month RevenueRevenue increased 25.9% quarter-over-quarter and 15.2% year-over-year to $13.7 million; six-month revenue rose 18.0% to $24.5 million, reporting a record first half and best quarter in the last 12 months.Sharply Reduced Net Loss and Fifth Straight Quarter of Adjusted EBITDA1 ImprovementQ2 net loss narrowed to $(2.1) million from $(21.8) million the same quarter last year, a 90.3% year-over-year improvement. Adjusted EBITDA loss improved to $(1.1) million from $(2.1) million from the prior year quarter — a 48.6% year-over-year improvement.Balance Sheet Strengthened Through Premium Capital RaisesOver $9 million in additional capital was raised at premiums...

BOSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today reported financial results for the third quarter 2025. On October 30, 2025, the Company announced that its Board of Directors determined, after extensive consideration of the Company’s development pipeline and current market conditions, to discontinue development of solnerstotug and initiate a comprehensive review of strategic alternatives aimed at maximizing shareholder value. The Company is exploring a range of strategic alternatives that may include, among other options, a sale of assets, licensing arrangements, collaborations, a sale of the Company, a business combination, a merger, or an orderly wind-down...

Hydroponic Basil, Potted Herbs, and Wheatgrass Accelerate; International Nutraceutical Sales Nearly Double Year-Over-Year Company’s Portfolio Optimization and Expansion into CEA-Informed, Better-For-You Shelf Stable Categories Pushes Market Penetration and Growth Conference Call to Be Held Today at 8:00 am ET. BELVIDERE, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced financial results for the third quarter ended September 30, 2025. The third quarter is traditionally the slowest of the year for Edible Garden, however the results reflect the early benefits of the Company’s strategic evolution toward a CEA informed...

MERIDIAN, Idaho, Nov. 14, 2025 (GLOBE NEWSWIRE) — PCS Edventures!, Inc. (“PCSV”), a leading provider of TK-12 Science, Technology, Engineering and Mathematics (“STEM”) education programs, today announced results of operations for its second quarter of fiscal year 2026, which ended on September 30, 2025. Second Quarter FY 2026 Overview:Revenue decreased 32.5% to $1,529,503 in the second quarter of FY 2026 compared to the prior year. Gross margin of 58.0% in the second quarter of FY 2026 compared to 59.7% in the second quarter of FY 2025. Net income before income tax provision was $0.00 million in the second quarter of FY 2026 versus $0.55 million in the previous year same quarter. During the quarter, shares outstanding declined 3.3% as 3,967,283 shares were repurchased.Mike Bledsoe, President, commented, “This quarter marked...